Cart
sales@molnova.com
Tracheloside
CAS No. 33464-71-0
Tracheloside ( —— )
Catalog No. M18434 CAS No. 33464-71-0
Tracheloside significantly decreases the activity of alkaline phosphatase (IC50: 0.31 μg/ml), a level of inhibition comparable to that of tamoxifen (IC50: 0.43 μg/ml).
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 86 | In Stock |
|
| 10MG | 149 | In Stock |
|
| 25MG | 270 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTracheloside
-
NoteResearch use only, not for human use.
-
Brief DescriptionTracheloside significantly decreases the activity of alkaline phosphatase (IC50: 0.31 μg/ml), a level of inhibition comparable to that of tamoxifen (IC50: 0.43 μg/ml).
-
DescriptionTracheloside significantly decreases the activity of alkaline phosphatase (IC50: 0.31 μg/ml), a level of inhibition comparable to that of tamoxifen (IC50: 0.43 μg/ml).
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptoralkaline phosphatase
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number33464-71-0
-
Formula Weight550.56
-
Molecular FormulaC27H34O12
-
Purity98%
-
Solubility——
-
SMILESO1C(=O)[C@@]([C@H](C1)Cc1cc(c(cc1)OC)OC)(Cc1cc(c(cc1)O[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)OC)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kitamura Y,et al. Cancer Lett. 2003 Oct 28;200(2):133-9.
molnova catalog
related products
-
72'-dihydroxy-3'4'-d...
72'-dihydroxy-3'4'-dimethoxyisoflavane-7-O-glucoside is a natural product from Astragalus membranaceus.
-
PJ34
PJ34 HCl is the hydrochloride salt of PJ34, which is a PARP inhibitor with EC50 of 20 nM and is equally potent to PARP1/2.
-
FFAGLDD TFA
FFAGLDD TFA is an MMP9 selective cleavage peptide, which is used for the cytoplasmic transfer of doxorubicin (DOX) to realize the controlled slow drug delivery and release.
